Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction)

Journal of Molecular and Cellular Cardiology

Volumn 94, Issue , 2016, Pages 107-121

  Chistiakov, Dimitry A ^a   Orekhov, Alexander N ^b,c,d   Bobryshev, Yuri V ^b,e,f  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

^d Institute for Atherosclerosis Research   (Russian Federation)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Heart; miR 1; miR 133a; miR 208a b; miR 499; Myocardial infarction

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; CYCLIN D2; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 4; KRUPPEL LIKE FACTOR 4; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MICRORNA 1; MICRORNA 133A; MICRORNA 208A; MICRORNA 208B; MICRORNA 499; RYANODINE RECEPTOR 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TRANSCRIPTION FACTOR GATA; UNCLASSIFIED DRUG;

APOPTOSIS; ARRHYTHMOGENESIS; AUTOMATION; CARDIAC MUSCLE CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; EARLY DIAGNOSIS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HEART CONDUCTION; HEART DEPOLARIZATION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE EXCITABILITY; HEART REPOLARIZATION; HUMAN; INTRON; MEMBRANE CONDUCTANCE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SARCOMERE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; ANTIBODY SPECIFICITY; CALCIUM SIGNALING; CARDIAC MUSCLE; CYTOLOGY; EMBRYOLOGY; EMBRYONIC STEM CELL; GENETICS; HEART; HEART DISEASES; METABOLISM; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CALCIUM SIGNALING; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; HEART; HEART DISEASES; HUMANS; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; ORGAN SPECIFICITY; OXIDATIVE STRESS;

EID: 85008686938     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2016.03.015     Document Type: Review

References (210)

1. [1] Frangogiannis, N.G., Smith, C.W., Entman, M.L., The inflammatory response in myocardial infarction. Cardiovasc. Res. 53 (2002), 31–47.
2. [2] Jessup, M., Brozena, S., Heart failure. N. Engl. J. Med. 348 (2003), 2007–2018.
3. [3] Waller, C., Hiller, K.H., Pfaff, D., Gattenlöhner, S., Ertl, G., Bauer, W.R., Functional mechanisms of myocardial microcirculation in left ventricular hypertrophy: a hypothetical model of capillary remodeling post myocardial infarction. Microvasc. Res. 75 (2008), 104–111.
4. [4] Duygu, B., de Windt, L.J., da Costa Martins, P.A., Targeting microRNAs in heart failure. Trends Cardiovasc. Med., 2015 pii: S1050-1738(15)00153-X.
5. [5] Friedman, R.C., Farh, K.K., Burge, C.B., Bartel, D.P., Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19 (2009), 92–105.
6. [6] Topkara, V.K., Mann, D.L., Role of microRNAs in cardiac remodeling and heart failure. Cardiovasc. Drugs Ther. 25 (2011), 171–182.
7. [7] da Costa Martins, P.A., Bourajjaj, M., Gladka, M., Kortland, M., van Oort, R.J., Pinto, Y.M., Molkentin, J.D., De Windt, L.J., Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation 118 (2008), 1567–1576.
8. [8] Piubelli, C., Meraviglia, V., Pompilio, G., D'Alessandra, Y., Colombo, G.I., Rossini, A., MicroRNAs and cardiac cell fate. Cells 3 (2014), 802–823.
9. [9] Li, J., Dong, X., Wang, Z., Wu, J., MicroRNA-1 in cardiac diseases and cancers. Korean J. Physiol. Pharmacol. 18 (2014), 359–363.
10. [10] Tani, S., Kuraku, S., Sakamoto, H., Inoue, K., Kusakabe, R., Developmental expression and evolution of muscle-specific microRNAs conserved in vertebrates. Evol. Dev. 15 (2013), 293–304.
11. [11] Kusakabe, R., Tani, S., Nishitsuji, K., Shindo, M., Okamura, K., Miyamoto, Y., Nakai, K., Suzuki, Y., Kusakabe, T.G., Inoue, K., Characterization of the compact bicistronic microRNA precursor, miR-1/miR-133, expressed specifically in Ciona muscle tissues. Gene Expr. Patterns 13 (2013), 43–50.
12. [12] Chen, J.F., Mandel, E.M., Thomson, J.M., Wu, Q., Callis, T.E., Hammond, S.M., Conlon, F.L., Wang, D.Z., The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38 (2006), 228–233.
13. [13] Zhao, Y., Samal, E., Srivastava, D., Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436 (2005), 214–220.
14. [14] Liu, N., Williams, A.H., Kim, Y., McAnally, J., Bezprozvannaya, S., Sutherland, L.B., Richardson, J.A., Bassel-Duby, R., Olson, E.N., An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 20844–20849.
15. [15] Mitchelson, K.R., Qin, W.Y., Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease. World J. Biol. Chem. 6 (2015), 162–208.
16. [16] Liu, N., Olson, E.N., MicroRNA regulatory networks in cardiovascular development. Dev. Cell 18 (2010), 510–525.
17. [17] Rachagani, S., Cheng, Y., Reecy, J.M., Myostatin genotype regulates muscle-specific miRNA expression in mouse pectoralis muscle. BMC Res. Notes, 3, 2010, 297.
18. [18] Yoon, M.S., Chen, J., Distinct amino acid-sensing mTOR pathways regulate skeletal myogenesis. Mol. Biol. Cell 24 (2013), 3754–3763.
19. [19] Sun, Y., Ge, Y., Drnevich, J., Zhao, Y., Band, M., Chen, J., Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis. J. Cell Biol. 189 (2010), 1157–1169.
20. [20] Iezzi, S., Di Padova, M., Serra, C., Caretti, G., Simone, C., Maklan, E., Minetti, G., Zhao, P., Hoffman, E.P., Puri, P.L., Sartorelli, V., Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. Dev. Cell 6 (2004), 673–684.
21. [21] Winbanks, C.E., Weeks, K.L., Thomson, R.E., Sepulveda, P.V., Beyer, C., Qian, H., Chen, J.L., Allen, J.M., Lancaster, G.I., Febbraio, M.A., Harrison, C.A., McMullen, J.R., Chamberlain, J.S., Gregorevic, P., Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin. J. Cell Biol. 197 (2012), 997–1008.
22. [22] King, I.N., Yartseva, V., Salas, D., Kumar, A., Heidersbach, A., Ando, D.M., Stallings, N.R., Elliott, J.L., Srivastava, D., Ivey, K.N., The RNA-binding protein TDP-43 selectively disrupts microRNA-1/206 incorporation into the RNA-induced silencing complex. J. Biol. Chem. 289 (2014), 14263–14271.
23. [23] Turner, C., Hilton-Jones, D., Myotonic dystrophy: diagnosis, management and new therapies. Curr. Opin. Neurol. 27 (2014), 599–606.
24. [24] Trabucchi, M., Briata, P., Garcia-Mayoral, M., Haase, A.D., Filipowicz, W., Ramos, A., Gherzi, R., Rosenfeld, M.G., The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 459 (2009), 1010–1014.
25. [25] Tao, G., Martin, J.F., MicroRNAs get to the heart of development. Elife, 2, 2013, e01710.
26. [26] Zhao, Y., Ransom, J.F., Li, A., Vedantham, V., von Drehle, M., Muth, A.N., Tsuchihashi, T., McManus, M.T., Schwartz, R.J., Srivastava, D., Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129 (2007), 303–317.
27. [27] Heidersbach, A., Saxby, C., Carver-Moore, K., Huang, Y., Ang, Y.S., de Jong, P.J., Ivey, K.N., Srivastava D. microRNA-1 regulates sarcomere formation and suppresses smooth muscle gene expression in the mammalian heart. Elife, 2, 2013, e01323.
28. [28] Terentyev, D., Belevych, A.E., Terentyeva, R., Martin, M.M., Malana, G.E., Kuhn, D.E., Abdellatif, M., Feldman, D.S., Elton, T.S., Györke, S., miR-1 overexpression enhances Ca(2 +) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2. Circ. Res. 104 (2009), 514–521.
29. [29] Wijnker, P.J., Boknik, P., Gergs, U., Müller, F.U., Neumann, J., dos Remedios, C., Schmitz, W., Sindermann, J.R., Stienen, G.J., van der Velden, J., Kirchhefer, U., Protein phosphatase 2 A affects myofilament contractility in non-failing but not in failing human myocardium. J. Muscle Res. Cell Motil. 32:3 (2011), 221–233.
30. [30] Ivey, K.N., Muth, A., Arnold, J., King, F.W., Yeh, R.F., Fish, J.E., Hsiao, E.C., Schwartz, R.J., Conklin, B.R., Bernstein, H.S., Srivastava, D., MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell 2 (2008), 219–229.
31. [31] Skerjanc, I.S., Petropoulos, H., Ridgeway, A.G., Wilton, S., Myocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 cells. J. Biol. Chem. 273 (1998), 34904–34910.
32. [32] Huang, F., Tang, L., Fang, Z.F., Hu, X.Q., Pan, J.Y., Zhou, S.H., miR-1-mediated induction of cardiogenesis in mesenchymal stem cells via downregulation of Hes-1. Biomed. Res. Int., 2013, 2013, 216286.
33. [33] Hatakeyama, J., Bessho, Y., Katoh, K., Ookawara, S., Fujioka, M., Guillemot, F., Kageyama, R., Hes genes regulate size, shape and histogenesis of the nervous system by control of the timing of neural stem cell differentiation. Development 131 (2004), 5539–5550.
34. [34] Takaya, T., Ono, K., Kawamura, T., Takanabe, R., Kaichi, S., Morimoto, T., Wada, H., Kita, T., Shimatsu, A., Hasegawa, K., MicroRNA-1 and MicroRNA-133 in spontaneous myocardial differentiation of mouse embryonic stem cells. Circ. J. 73 (2009), 1492–1497.
35. [35] Kaichi, S., Takaya, T., Morimoto, T., Sunagawa, Y., Kawamura, T., Ono, K., Shimatsu, A., Baba, S., Heike, T., Nakahata, T., Hasegawa, K., Cyclin-dependent kinase 9 forms a complex with GATA4 and is involved in the differentiation of mouse ES cells into cardiomyocytes. J. Cell. Physiol. 226 (2011), 248–254.
36. [36] Lu, J., McKinsey, T.A., Zhang, C.L., Olson, E.N., Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell 6 (2000), 233–244.
37. [37] Schneider, M., Andersen, D.C., Silahtaroglu, A., Lyngbæk, S., Kauppinen, S., Hansen, J.L., Sheikh, S.P., Cell-specific detection of microRNA expression during cardiomyogenesis by combined in situ hybridization and immunohistochemistry. J. Mol. Histol. 42 (2011), 289–299.
38. [38] Synnergren, J., Améen, C., Lindahl, A., Olsson, B., Sartipy, P., Expression of microRNAs and their target mRNAs in human stem cell-derived cardiomyocyte clusters and in heart tissue. Physiol. Genomics 43 (2011), 581–594.
39. [39] Synnergren, J., Améen, C., Jansson, A., Sartipy, P., Global transcriptional profiling reveals similarities and differences between human stem cell-derived cardiomyocyte clusters and heart tissue. Physiol. Genomics 44 (2012), 245–258.
40. [40] King, I.N., Qian, L., Liang, J., Huang, Y., Shieh, J.T., Kwon, C., Srivastava, D., A genome-wide screen reveals a role for microRNA-1 in modulating cardiac cell polarity. Dev. Cell 20 (2011), 497–510.
41. [41] Lu, T.Y., Lin, B., Li, Y., Arora, A., Han, L., Cui, C., Coronnello, C., Sheng, Y., Benos, P.V., Yang, L., Overexpression of microRNA-1 promotes cardiomyocyte commitment from human cardiovascular progenitors via suppressing WNT and FGF signaling pathways. J. Mol. Cell. Cardiol. 63 (2013), 146–154.
42. [42] Wang, D., Chang, P.S., Wang, Z., Sutherland, L., Richardson, J.A., Small, E., Krieg, P.A., Olson, E.N., Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105 (2001), 851–862.
43. [43] Chen, J., Yin, H., Jiang, Y., Radhakrishnan, S.K., Huang, Z.P., Li, J., Shi, Z., Kilsdonk, E.P., Gui, Y., Wang, D.Z., Zheng, X.L., Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation. Arterioscler. Thromb. Vasc. Biol. 31 (2011), 368–375.
44. [44] Xie, C., Huang, H., Sun, X., Guo, Y., Hamblin, M., Ritchie, R.P., Garcia-Barrio, M.T., Zhang, J., Chen, Y.E., MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4. Stem Cells Dev. 20 (2011), 205–210.
45. [45] Wystub, K., Besser, J., Bachmann, A., Boettger, T., Braun, T., miR-1/133a clusters cooperatively specify the cardiomyogenic lineage by adjustment of myocardin levels during embryonic heart development. PLoS Genet., 9, 2013, e1003793.
46. [46] Jayawardena, T.M., Egemnazarov, B., Finch, E.A., Zhang, L., Payne, J.A., Pandya, K., Zhang, Z., Rosenberg, P., Mirotsou, M., Dzau, V.J., MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ. Res. 110 (2012), 1465–1473.
47. [47] Jayawardena, T.M., Finch, E.A., Zhang, L., Zhang, H., Hodgkinson, C.P., Pratt, R.E., Rosenberg, P.B., Mirotsou, M., Dzau, V.J., MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ. Res. 116 (2015), 418–424.
48. [48] Nam, Y.J., Song, K., Luo, X., Daniel, E., Lambeth, K., West, K., Hill, J.A., DiMaio, J.M., Baker, L.A., Bassel-Duby, R., Olson, E.N., Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 5588–5593.
49. [49] Marbán, E., Cardiac channelopathies. Nature 415 (2002), 213–218.
50. [50] Kim, G.H., MicroRNA regulation of cardiac conduction and arrhythmias. Transl. Res. 161 (2013), 381–392.
51. [51] Klugbauer, N., Welling, A., Specht, V., Seisenberger, C., Hofmann, F., L-type Ca2 + channels of the embryonic mouse heart. Eur. J. Pharmacol. 447 (2002), 279–284.
52. 2 + channel activity induces hypertrophy and heart failure in mice. J. Clin. Invest. 122 (2012), 280–290.
53. [53] Furling, D., Misregulation of alternative splicing and microRNA processing in DM1 pathogenesis. Rinsho Shinkeigaku 52 (2012), 1018–1022.
54. [54] Nerbonne, J.M., Dorn, G.W. 2nd., MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ. Res. 106 (2010), 166–175.
55. [55] Zhao, Y., Ransom, J.F., Li, A., Vedantham, V., von Drehle, M., Muth, A.N., Tsuchihashi, T., McManus, M.T., Schwartz, R.J., Srivastava, D., Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129 (2007), 303–317.
56. [56] Costantini, D.L., Arruda, E.P., Agarwal, P., Kim, K.H., Zhu, Y., Zhu, W., Lebel, M., Cheng, C.W., Park, C.Y., Pierce, S.A., Guerchicoff, A., Pollevick, G.D., Chan, T.Y., Kabir, M.G., Cheng, S.H., Husain, M., Antzelevitch, C., Srivastava, D., Gross, G.J., Hui, C.C., Backx, P.H., Bruneau, B.G., The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient. Cell 123 (2005), 347–358.
57. [57] Yang, B., Lin, H., Xiao, J., Lu, Y., Luo, X., Li, B., Zhang, Y., Xu, C., Bai, Y., Wang, H., Chen, G., Wang, Z., The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med. 13 (2007), 486–491.
58. [58] Shan, H., Zhang, Y., Cai, B., Chen, X., Fan, Y., Yang, L., Chen, X., Liang, H., Zhang, Y., Song, X., Xu, C., Lu, Y., Yang, B., Du, Z., Up-regulation of microRNA-1 and microRNA-133 contributes to arsenic-induced cardiac electrical remodeling. Int. J. Cardiol. 167 (2013), 2798–2805.
59. [59] Barbey, J.T., Pezzullo, J.C., Soignet, S.L., Effect of arsenic trioxide on QT interval in patients with advanced malignancies. J. Clin. Oncol. 21 (2003), 3609–3615.
60. [60] Girmatsion, Z., Biliczki, P., Bonauer, A., Wimmer-Greinecker, G., Scherer, M., Moritz, A., Bukowska, A., Goette, A., Nattel, S., Hohnloser, S.H., Ehrlich, J.R., Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation. Heart Rhythm. 6 (2009), 1802–1809.
61. [61] Yamakage, M., Namiki, A., Calcium channels–basic aspects of their structure, function and gene encoding; anesthetic action on the channels–a review. Can. J. Anaesth. 49 (2002), 151–164.
62. [62] Aronsen, J.M., Swift, F., Sejersted, O.M., Cardiac sodium transport and excitation-contraction coupling. J. Mol. Cell. Cardiol. 61 (2013), 11–19.
63. [63] Tritsch, E., Mallat, Y., Lefebvre, F., Diguet, N., Escoubet, B., Blanc, J., De Windt, L.J., Catalucci, D., Vandecasteele, G., Li, Z., Mericskay, M., An SRF/miR 1 axis regulates NCX1 and annexin A5 protein levels in the normal and failing heart. Cardiovasc. Res. 98 (2013), 372–380.
64. [64] DiPolo, R., Beaugé, L., Sodium/calcium exchanger: influence of metabolic regulation on ion carrier interactions. Physiol. Rev. 86 (2006), 155–203.
65. [65] Pogwizd, S.M., Schlotthauer, K., Li, L., Yuan, W., Bers, D.M., Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ. Res. 88 (2001), 1159–1167.
66. [66] Pogwizd, S.M., Bers, D.M., Calcium cycling in heart failure: the arrhythmia connection. J. Cardiovasc. Electrophysiol. 13 (2002), 88–91.
67. [67] Ai, X., Curran, J.W., Shannon, T.R., Bers, D.M., Pogwizd, S.M., Ca2 +/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2 + leak in heart failure. Circ. Res. 97 (2005), 1314–1322.
68. [68] Belevych, A.E., Sansom, S.E., Terentyeva, R., Ho, H.T., Nishijima, Y., Martin, M.M., Jindal, H.K., Rochira, J.A., Kunitomo, Y., Abdellatif, M., Carnes, C.A., Elton, T.S., Györke, S., Terentyev, D., MicroRNA-1 and -133 increase arrhythmogenesis in heart failure by dissociating phosphatase activity from RyR2 complex. PLoS One, 6, 2011, e28324.
69. [69] Kumarswamy, R., Lyon, A.R., Volkmann, I., Mills, A.M., Bretthauer, J., Pahuja, A., Geers-Knörr, C., Kraft, T., Hajjar, R.J., Macleod, K.T., Harding, S.E., Thum, T., SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway. Eur. Heart J. 33 (2012), 1067–1075.
70. [70] Stroemlund, L.W., Jensen, C.F., Qvortrup, K., Delmar, M., Nielsen, M.S., Gap junctions — guards of excitability. Biochem. Soc. Trans. 43 (2015), 508–512.
71. [71] Yao, J.A., Hussain, W., Patel, P., Peters, N.S., Boyden, P.A., Wit, A.L., Remodeling of gap junctional channel function in epicardial border zone of healing canine infarcts. Circ. Res. 92 (2003), 437–443.
72. [72] Cabo, C., Yao, J., Boyden, P.A., Chen, S., Hussain, W., Duffy, H.S., Ciaccio, E.J., Peters, N.S., Wit, A.L., Heterogeneous gap junction remodeling in reentrant circuits in the epicardial border zone of the healing canine infarct. Cardiovasc. Res. 72 (2006), 241–249.
73. [73] Nattel, S., Maguy, A., Le Bouter, S., Yeh, Y.H., Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol. Rev. 87 (2007), 425–456.
74. [74] Xu, H.F., Ding, Y.J., Shen, Y.W., Xue, A.M., Xu, H.M., Luo, C.L., Li, B.X., Liu, Y.L., Zhao, Z.Q., MicroRNA-1 represses Cx43 expression in viral myocarditis. Mol. Cell. Biochem. 362 (2012), 141–148.
75. [75] Klotz, L.O., Posttranscriptional regulation of connexin-43 expression. Arch. Biochem. Biophys. 524 (2012), 23–29.
76. [76] Lu, Y., Zhang, Y., Shan, H., Pan, Z., Li, X., Li, B., Xu, C., Zhang, B., Zhang, F., Dong, D., Song, W., Qiao, G., Yang, B., MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. Cardiovasc. Res. 84 (2009), 434–441.
77. [77] Zhang, Y., Zhang, L., Chu, W., Wang, B., Zhang, J., Zhao, M., Li, X., Li, B., Lu, Y., Yang, B., Shan, H., Tanshinone IIA inhibits miR-1 expression through p38 MAPK signal pathway in post-infarction rat cardiomyocytes. Cell. Physiol. Biochem. 26 (2010), 991–998.
78. [78] Curcio, A., Torella, D., Iaconetti, C., Pasceri, E., Sabatino, J., Sorrentino, S., Giampà, S., Micieli, M., Polimeni, A., Henning, B.J., Leone, A., Catalucci, D., Ellison, G.M., Condorelli, G., Indolfi, C., MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts. PLoS One, 8, 2013, e70158.
79. [79] Allessie, M.A., Bonke, F.I., Schopman, F.J., Circus movement in rabbit atrial muscle as a mechanism of tachycardia. II. The role of nonuniform recovery of excitability in the occurrence of unidirectional block, as studied with multiple microelectrodes. Circ. Res. 39 (1976), 168–177.
80. [80] Long, G., Wang, F., Duan, Q., Chen, F., Yang, S., Gong, W., Wang, Y., Chen, C., Wang, D.W., Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. Int. J. Biol. Sci. 8 (2012), 811–818.
81. [81] Li, C., Fang, Z., Jiang, T., Zhang, Q., Liu, C., Zhang, C., Xiang, Y., Serum microRNAs profile from genome-wide serves as a fingerprint for diagnosis of acute myocardial infarction and angina pectoris. BMC Med. Genet., 6, 2013, 16.
82. [82] D'Alessandra, Y., Devanna, P., Limana, F., Straino, S., Di Carlo, A., Brambilla, P.G., Rubino, M., Carena, M.C., Spazzafumo, L., De Simone, M., Micheli, B., Biglioli, P., Achilli, F., Martelli, F., Maggiolini, S., Marenzi, G., Pompilio, G., Capogrossi, M.C., Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur. Heart J. 31 (2010), 2765–2773.
83. [83] Cheng, Y., Tan, N., Yang, J., Liu, X., Cao, X., He, P., Dong, X., Qin, S., Zhang, C., A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin. Sci. (Lond.) 119 (2010), 87–95.
84. [84] Pan, Z., Sun, X., Ren, J., Li, X., Gao, X., Lu, C., Zhang, Y., Sun, H., Wang, Y., Wang, H., Wang, J., Xie, L., Lu, Y., Yang, B., miR-1 exacerbates cardiac ischemia-reperfusion injury in mouse models. PLoS One, 7, 2012, e50515.
85. [85] Tang, Y., Zheng, J., Sun, Y., Wu, Z., Liu, Z., Huang, G., MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int. Heart J. 50 (2009), 377–387.
86. [86] Xu, C., Lu, Y., Pan, Z., Chu, W., Luo, X., Lin, H., Xiao, J., Shan, H., Wang, Z., Yang, B., The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J. Cell Sci. 120:Pt 17 (2007), 3045–3052.
87. [87] Yu, X.Y., Song, Y.H., Geng, Y.J., Lin, Q.X., Shan, Z.X., Lin, S.G., Li, Y., Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1. Biochem. Biophys. Res. Commun. 376 (2008), 548–552.
88. [88] Shan, Z.X., Lin, Q.X., Deng, C.Y., Zhu, J.N., Mai, L.P., Liu, J.L., Fu, Y.H., Liu, X.Y., Li, Y.X., Zhang, Y.Y., Lin, S.G., Yu, X.Y., miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes. FEBS Lett. 584 (2010), 3592–3600.
89. [89] Elia, L., Contu, R., Quintavalle, M., Varrone, F., Chimenti, C., Russo, M.A., Cimino, V., De Marinis, L., Frustaci, A., Catalucci, D., Condorelli, G., Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 120 (2009), 2377–2385.
90. [90] Kumarswamy, R., Lyon, A.R., Volkmann, I., Mills, A.M., Bretthauer, J., Pahuja, A., Geers-Knörr, C., Kraft, T., Hajjar, R.J., Macleod, K.T., Harding, S.E., Thum, T., SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway. Eur. Heart J. 33 (2012), 1067–1075.
91. [91] Li, Y., Shelat, H., Geng, Y.J., IGF-1 prevents oxidative stress induced-apoptosis in induced pluripotent stem cells which is mediated by microRNA-1. Biochem. Biophys. Res. Commun. 426 (2012), 615–619.
92. [92] Suffredini, S., Stillitano, F., Comini, L., Bouly, M., Brogioni, S., Ceconi, C., Ferrari, R., Mugelli, A., Cerbai, E., Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression. Br. J. Pharmacol. 165 (2012), 1457–1466.
93. [93] Michels, G., Brandt, M.C., Zagidullin, N., Khan, I.F., Larbig, R., van Aaken, S., Wippermann, J., Hoppe, U.C., Direct evidence for calcium conductance of hyperpolarization-activated cyclic nucleotide-gated channels and human native If at physiological calcium concentrations. Cardiovasc. Res. 78 (2008), 466–475.
94. [94] Michels, G., Er, F., Khan, I., Südkamp, M., Herzig, S., Hoppe, U.C., Single-channel properties support a potential contribution of hyperpolarization-activated cyclic nucleotide-gated channels and If to cardiac arrhythmias. Circulation 111 (2005), 399–404.
95. [95] Myers, R., Timofeyev, V., Li, N., Kim, C., Ledford, H.A., Sirish, P., Lau, V., Zhang, Y., Fayyaz, K., Singapuri, A., Lopez, J.E., Knowlton, A.A., Zhang, X.D., Chiamvimonvat, N., Feedback mechanisms for cardiac-specific microRNAs and cAMP signaling in electrical remodeling. Circ. Arrhythm. Electrophysiol. 8 (2015), 942–950.
96. [96] Schömig, A., Richardt, G., Kurz, T., Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact. Herz 20 (1995), 169–186.
97. [97] Wang, L., Yuan, Y., Li, J., Ren, H., Cai, Q., Chen, X., Liang, H., Shan, H., Fu, Z.D., Gao, X., Lv, Y., Yang, B., Zhang, Y., MicroRNA-1 aggravates cardiac oxidative stress by post-transcriptional modification of the antioxidant network. Cell Stress Chaperones 20 (2015), 411–420.
98. [98] Chen, T., Ding, G., Jin, Z., Wagner, M.B., Yuan, Z., Insulin ameliorates miR-1-induced injury in H9c2 cells under oxidative stress via Akt activation. Mol. Cell. Biochem. 369 (2012), 167–174.
99. [99] Kozakowska, M., Ciesla, M., Stefanska, A., Skrzypek, K., Was, H., Jazwa, A., Grochot-Przeczek, A., Kotlinowski, J., Szymula, A., Bartelik, A., Mazan, M., Yagensky, O., Florczyk, U., Lemke, K., Zebzda, A., Dyduch, G., Nowak, W., Szade, K., Stepniewski, J., Majka, M., Derlacz, R., Loboda, A., Dulak, J., Jozkowicz, A., Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs. Antioxid. Redox Signal. 16 (2012), 113–127.
100. [100] Kuwabara, Y., Ono, K., Horie, T., Nishi, H., Nagao, K., Kinoshita, M., Watanabe, S., Baba, O., Kojima, Y., Shizuta, S., Imai, M., Tamura, T., Kita, T., Kimura, T., Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ. Cardiovasc. Genet. 4 (2011), 446–454.
101. [101] Wang, G.K., Zhu, J.Q., Zhang, J.T., Li, Q., Li, Y., He, J., Qin, Y.W., Jing, Q., Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur. Heart J. 31 (2010), 659–666.
102. [102] Widera, C., Gupta, S.K., Lorenzen, J.M., Bang, C., Bauersachs, J., Bethmann, K., Kempf, T., Wollert, K.C., Thum, T., Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J. Mol. Cell. Cardiol. 51 (2011), 872–875.
103. [103] Li, Y.Q., Zhang, M.F., Wen, H.Y., Hu, C.L., Liu, R., Wei, H.Y., Ai, C.M., Wang, G., Liao, X.X., Li, X., Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction. Clinics (Sao Paulo) 68 (2013), 75–80.
104. [104] Gidlöf, O., Andersson, P., van der Pals, J., Götberg, M., Erlinge, D., Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology 118 (2011), 217–226.
105. [105] Heusch, G., Bøtker, H.E., Przyklenk, K., Redington, A., Yellon, D., Remote ischemic conditioning. J. Am. Coll. Cardiol. 65 (2015), 177–195.
106. [106] Duan, X., Ji, B., Wang, X., Liu, J., Zheng, Z., Long, C., Tang, Y., Hu, S., Expression of microRNA-1 and microRNA-21 in different protocols of ischemic conditioning in an isolated rat heart model. Cardiology 122 (2012), 36–43.
107. [107] Brandenburger, T., Grievink, H., Heinen, N., Barthel, F., Huhn, R., Stachuletz, F., Kohns, M., Pannen, B., Bauer, I., Effects of remote ischemic preconditioning and myocardial ischemia on microRNA-1 expression in the rat heart in vivo. Shock 42 (2014), 234–238.
108. [108] Slagsvold, K.H., Rognmo, O., Høydal, M., Wisløff, U., Wahba, A., Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery. Circ. Res. 114 (2014), 851–859.
109. [109] Hua, Y., Zhang, Y., Ren, J., IGF-1 deficiency resists cardiac hypertrophy and myocardial contractile dysfunction: role of microRNA-1 and microRNA-133a. J. Cell. Mol. Med. 16 (2012), 83–95.
110. [110] Karakikes, I., Chaanine, A.H., Kang, S., Mukete, B.N., Jeong, D., Zhang, S., Hajjar, R.J., Lebeche, D., Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling. J. Am. Heart Assoc., 2, 2013, e000078.
111. [111] Glass, C., Singla, D.K., MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart. Am. J. Physiol. Heart Circ. Physiol. 301 (2011), H2038–H2049.
112. [112] Glass, C., Singla, D.K., ES cells overexpressing microRNA-1 attenuate apoptosis in the injured myocardium. Mol. Cell. Biochem. 357 (2011), 135–141.
113. [113] Yu, H., Lu, Y., Li, Z., Wang, Q., microRNA-133: expression, function and therapeutic potential in muscle diseases and cancer. Curr. Drug Targets 15 (2014), 817–828.
114. [114] Chen, M., Herring, B.P., Regulation of microRNAs by Brahma-related gene 1 (Brg1) in smooth muscle cells. J. Biol. Chem. 288 (2013), 6397–6408.
115. [115] Zhang, M., Chen, M., Kim, J.R., Zhou, J., Jones, R.E., Tune, J.D., Kassab, G.S., Metzger, D., Ahlfeld, S., Conway, S.J., Herring, B.P., SWI/SNF complexes containing Brahma or Brahma-related gene 1 play distinct roles in smooth muscle development. Mol. Cell. Biol. 31 (2011), 2618–2631.
116. [116] Mallappa, C., Nasipak, B.T., Etheridge, L., Androphy, E.J., Jones, S.N., Sagerström, C.G., Ohkawa, Y., Imbalzano, A.N., Myogenic microRNA expression requires ATP-dependent chromatin remodeling enzyme function. Mol. Cell. Biol. 30 (2010), 3176–3186.
117. [117] Porrello, E.R., microRNAs in cardiac development and regeneration. Clin. Sci. (Lond.) 125 (2013), 151–166.
118. [118] Boettger, T., Wüst, S., Nolte, H., Braun, T., The miR 206/133b cluster is dispensable for development, survival and regeneration of skeletal muscle. Skelet. Muscle, 4, 2014, 23.
119. [119] Koutsoulidou, A., Mastroyiannopoulos, N.P., Furling, D., Uney, J.B., Phylactou, L.A., Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle. BMC Dev. Biol., 11, 2011, 34.
120. [120] Liu, N., Bezprozvannaya, S., Williams, A.H., Qi, X., Richardson, J.A., Bassel-Duby, R., Olson, E.N., microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev. 22 (2008), 3242–3254.
121. [121] Izarra, A., Moscoso, I., Cañón, S., Carreiro, C., Fondevila, D., Martín-Caballero, J., Blanca, V., Valiente, I., Díez-Juan, A., Bernad, A., miRNA-1 and miRNA-133a are involved in early commitment of pluripotent stem cells and demonstrate antagonistic roles in the regulation of cardiac differentiation. J. Tissue Eng. Regen. Med., 2014, 10.1002/term.1977 (Epub ahead of print).
122. [122] Lee, S.Y., Ham, O., Cha, M.J., Song, B.W., Choi, E., Kim, I.K., Chang, W., Lim, S., Lee, C.Y., Park, J.H., Lee, J., Bae, Y., Seo, H.H., Choi, E., Jang, Y., Hwang, K.C., The promotion of cardiogenic differentiation of hMSCs by targeting epidermal growth factor receptor using microRNA-133a. Biomaterials 34 (2013), 92–99.
123. [123] Zhang, D., Li, X., Chen, C., Li, Y., Zhao, L., Jing, Y., Liu, W., Wang, X., Zhang, Y., Xia, H., Chang, Y., Gao, X., Yan, J., Ying, H., Attenuation of p38-mediated miR-1/133 expression facilitates myoblast proliferation during the early stage of muscle regeneration. PLoS One, 7, 2012, e41478.
124. [124] Muraoka, N., Yamakawa, H., Miyamoto, K., Sadahiro, T., Umei, T., Isomi, M., Nakashima, H., Akiyama, M., Wada, R., Inagawa, K., Nishiyama, T., Kaneda, R., Fukuda, T., Takeda, S., Tohyama, S., Hashimoto, H., Kawamura, Y., Goshima, N., Aeba, R., Yamagishi, H., Fukuda, K., Ieda, M., MiR-133 promotes cardiac reprogramming by directly repressing snai1 and silencing fibroblast signatures. EMBO J. 33 (2014), 1565–1581.
125. [125] Christoforou, N., Chellappan, M., Adler, A.F., Kirkton, R.D., Wu, T., Addis, R.C., Bursac, N., Leong, K.W., Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming. PLoS One, 8, 2013, e63577.
126. [126] Currie, S., Cardiac ryanodine receptor phosphorylation by CaM Kinase II: keeping the balance right. Front. Biosci. (Landmark Ed) 14 (2009), 5134–5156.
127. [127] Xiao, L., Xiao, J., Luo, X., Lin, H., Wang, Z., Nattel, S., Feedback remodeling of cardiac potassium current expression: a novel potential mechanism for control of repolarization reserve. Circulation 118 (2008), 983–992.
128. [128] Luo, X., Lin, H., Pan, Z., Xiao, J., Zhang, Y., Lu, Y., Yang, B., Wang, Z., Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. J. Biol. Chem. 283 (2008), 20045–20052.
129. [129] Xiao, J., Luo, X., Lin, H., Zhang, Y., Lu, Y., Wang, N., Zhang, Y., Yang, B., Wang, Z., MicroRNA miR-133 represses HERG K + channel expression contributing to QT prolongation in diabetic hearts. J. Biol. Chem. 282 (2007), 12363–12367.
130. [130] Zhang, Y., Xiao, J., Wang, H., Luo, X., Wang, J., Villeneuve, L.R., Zhang, H., Bai, Y., Yang, B., Wang, Z., Restoring depressed HERG K + channel function as a mechanism for insulin treatment of abnormal QT prolongation and associated arrhythmias in diabetic rabbits. Am. J. Physiol. Heart Circ. Physiol. 291 (2006), H1446–H1455.
131. [131] Matkovich, S.J., Wang, W., Tu, Y., Eschenbacher, W.H., Dorn, L.E., Condorelli, G., Diwan, A., Nerbonne, J.M., Dorn, G.W. 2nd., MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ. Res. 106 (2010), 166–175.
132. [132] Duisters, R.F., Tijsen, A.J., Schroen, B., Leenders, J.J., Lentink, V., van der Made, I., Herias, V., van Leeuwen, R.E., Schellings, M.W., Barenbrug, P., Maessen, J.G., Heymans, S., Pinto, Y.M., Gidlöf, O., Smith, J.G., Miyazu, K., Gilje, P., Spencer, A., Blomquist, S., Erlinge, D., Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction. BMC Cardiovasc. Disord., 13, 2013, 12.
133. [133] Abdellatif, M., The role of microRNA-133 in cardiac hypertrophy uncovered. Circ. Res. 106 (2010), 16–18.
134. [134] Dong, D.L., Chen, C., Huo, R., Wang, N., Li, Z., Tu, Y.J., Hu, J.T., Chu, X., Huang, W., Yang, B.F., Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy. Hypertension 55 (2010), 946–952.
135. [135] Li, Q., Lin, X., Yang, X., Chang, J., NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression. Am. J. Physiol. Heart Circ. Physiol. 298 (2010), H1340–H1347.
136. [136] Jeong, D., Kim, J.M., Cha, H., Oh, J.G., Park, J., Yun, S.H., Ju, E.S., Jeon, E.S., Hajjar, R.J., Park, W.J., PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling. Circ. Res. 102 (2008), 711–719.
137. [137] Diniz, G.P., Lino, C.A., Guedes, E.C., Moreira Ldo, N., Barreto-Chaves, M.L., Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via type 1 angiotensin II receptor. Basic Res. Cardiol., 110, 2015, 49.
138. [138] Roden, D.M., Repolarization reserve: a moving target. Circulation 118:10 (2008), 981–982.
139. [139] Bostjancic, E., Zidar, N., Glavac, D., MicroRNA microarray expression profiling in human myocardial infarction. Dis. Markers 27 (2009), 255–268.
140. [140] Bostjancic, E., Zidar, N., Stajer, D., Glavac, D., MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 115 (2010), 163–169.
141. [141] Cheng, C., Wang, Q., You, W., Chen, M., Xia, J., MiRNAs as biomarkers of myocardial infarction: a meta-analysis. PLoS One, 9, 2014, e88566.
142. [142] Wang, F., Long, G., Zhao, C., Li, H., Chaugai, S., Wang, Y., Chen, C., Wang, D.W., Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis. J. Transl. Med., 11, 2013, 222.
143. [143] Devaux, Y., Mueller, M., Haaf, P., Goretti, E., Twerenbold, R., Zangrando, J., Vausort, M., Reichlin, T., Wildi, K., Moehring, B., Wagner, D.R., Mueller, C., Diagnostic and prognostic value of circulating microRNAs in patients with acute chest pain. J. Intern. Med. 277 (2015), 260–271.
144. [144] Li, S., Xiao, F.Y., Shan, P.R., Su, L., Chen, D.L., Ding, J.Y., Wang, Z.Q., Overexpression of microRNA-133a inhibits ischemia-reperfusion-induced cardiomyocyte apoptosis by targeting DAPK2. J. Hum. Genet. 60 (2015), 709–716.
145. [145] He, B., Xiao, J., Ren, A.J., Zhang, Y.F., Zhang, H., Chen, M., Xie, B., Gao, X.G., Wang, Y.W., Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J. Biomed. Sci., 18, 2011, 22.
146. [146] Dakhlallah, D., Zhang, J., Yu, L., Marsh, C.B., Angelos, M.G., Khan, M., MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart. J. Cardiovasc. Pharmacol. 65 (2015), 241–251.
147. [147] Izarra, A., Moscoso, I., Levent, E., Cañón, S., Cerrada, I., Díez-Juan, A., Blanca, V., Núñez-Gil, I.J., Valiente, I., Ruíz-Sauri, A., Sepúlveda, P., Tiburcy, M., Zimmermann, W.H., Bernad, A., miR-133a enhances the protective capacity of cardiac progenitors cells after myocardial infarction. Stem Cell Rep. 3 (2014), 1029–1042.
148. [148] Kawai, T., Nomura, F., Hoshino, K., Copeland, N.G., Gilbert, D.J., Jenkins, N.A., Akira, S., Death-associated protein kinase 2 is a new calcium/calmodulin-dependent protein kinase that signals apoptosis through its catalytic activity. Oncogene 18 (1999), 3471–3480.
149. [149] Chen, S., Puthanveetil, P., Feng, B., Matkovich, S.J., Dorn, G.W. 2nd, Chakrabarti, S., Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes. J. Cell. Mol. Med. 18 (2014), 415–421.
150. [150] Sang, H.Q., Jiang, Z.M., Zhao, Q.P., Xin, F., MicroRNA-133a improves the cardiac function and fibrosis through inhibiting Akt in heart failure rats. Biomed. Pharmacother. 71 (2015), 185–189.
151. [151] Castoldi, G., Di Gioia, C.R., Bombardi, C., Catalucci, D., Corradi, B., Gualazzi, M.G., Leopizzi, M., Mancini, M., Zerbini, G., Condorelli, G., Stella, A., MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension. J. Cell. Physiol. 227 (2012), 850–856.
152. [152] Chaanine, A.H., Hajjar, R.J., AKT signalling in the failing heart. Eur. J. Heart Fail. 13 (2011), 825–829.
153. [153] Huang, Y., Li, J., MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker. J. Physiol. Biochem. 71 (2015), 479–486.
154. [154] Sayed, A.S., Xia, K., Yang, T.L., Peng, J., Circulating microRNAs: a potential role in diagnosis and prognosis of acute myocardial infarction. Dis. Markers 35 (2013), 561–566.
155. [155] Mahdavi, V., Chambers, A.P., Nadal-Ginard, B., Cardiac alpha- and beta-myosin heavy chain genes are organized in tandem. Proc. Natl. Acad. Sci. U. S. A. 81 (1984), 2626–2630.
156. [156] McGuigan, K., Phillips, P.C., Postlethwait, J.H., Evolution of sarcomeric myosin heavy chain genes: evidence from fish. Mol. Biol. Evol. 21 (2004), 1042–1056.
157. [157] Malizia, A.P., Wang, D.Z., MicroRNAs in cardiomyocyte development. Wiley Interdiscip. Rev. Syst. Biol. Med. 3 (2011), 183–190.
158. [158] McKinsey, T.A., Zhang, C.L., Olson, E.N., Signaling chromatin to make muscle. Curr. Opin. Cell Biol. 14 (2002), 763–772.
159. [159] Potthoff, M.J., Olson, E.N., MEF2: a central regulator of diverse developmental programs. Development 134 (2007), 4131–4140.
160. [160] Oliveira-Carvalho, V., Carvalho, V.O., Bocchi, E.A., The emerging role of miR-208a in the heart. DNA Cell Biol. 32 (2013), 8–12.
161. [161] van Rooij, E., Sutherland, L.B., Qi, X., Richardson, J.A., Hill, J., Olson, E.N., Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316 (2007), 575–579.
162. [162] van Rooij, E., Quiat, D., Johnson, B.A., Sutherland, L.B., Qi, X., Richardson, J.A., Kelm, R.J. Jr., Olson, E.N., A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev. Cell 17 (2009), 662–673.
163. [163] Callis, T.E., Pandya, K., Seok, H.Y., Tang, R.H., Tatsuguchi, M., Huang, Z.P., Chen, J.F., Deng, Z., Gunn, B., Shumate, J., Willis, M.S., Selzman, C.H., Wang, D.Z., MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J. Clin. Invest. 119 (2009), 2772–2786.
164. [164] Han, P., Li, W., Lin, C.H., Yang, J., Shang, C., Nurnberg, S.T., Jin, K.K., Xu, W., Lin, C.Y., Lin, C.J., Xiong, Y., Chien, H.C., Zhou, B., Ashley, E., Bernstein, D., Chen, P.S., Chen, H.S., Quertermous, T., Chang, C.P., A long noncoding RNA protects the heart from pathological hypertrophy. Nature 514 (2014), 102–106.
165. [165] van Rooij, E., Olson, E.N., MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J. Clin. Invest. 117 (2007), 2369–2376.
166. [166] van Rooij, E., Olson, E.N., microRNAs put their signatures on the heart. Physiol. Genomics 31 (2007), 365–366.
167. [167] van Rooij, E., Sutherland, L.B., Qi, X., Richardson, J.A., Hill, J., Olson, E.N., Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316 (2007), 575–579.
168. [168] Dillmann, W., Cardiac hypertrophy and thyroid hormone signaling. Heart Fail. Rev. 15 (2010), 125–132.
169. [169] Diniz, G.P., Takano, A.P., Barreto-Chaves, M.L., MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy — role of type 1 angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation. Mol. Cell. Endocrinol. 374 (2013), 117–124.
170. [170] Dóka, G., Radik, M., Krenek, P., Kyselovic, J., Klimas, J., 1 A.02: microRNA-208a and its host gene cardiac myosin heavy chain MYH6 are involved in hypertrophic heart dysfunction. J. Hypertens., 33;Suppl. 1:e1, 2015.
171. [171] Wu, A.H., Feng, Y.J., Moore, R., Apple, F.S., McPherson, P.H., Buechler, K.F., Bodor, G., Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. Clin. Chem. 44:6 Pt 1 (1998), 1198–1208.
172. [172] Abbas, N.A., John, R.I., Webb, M.C., Kempson, M.E., Potter, A.N., Price, C.P., Vickery, S., Lamb, E.J., Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin. Chem. 51 (2005), 2059–2066.
173. [173] Liu, L., Aguirre, S.A., Evering, W.E., Hirakawa, B.P., May, J.R., Palacio, K., Wang, J., Zhang, Y., Stevens, G.J., miR-208a as a biomarker of isoproterenol-induced cardiac injury in Sod2 ±- and C57BL/6 J wild-type mice. Toxicol. Pathol. 42 (2014), 1117–1129.
174. [174] Corsten, M.F., Dennert, R., Jochems, S., Kuznetsova, T., Devaux, Y., Hofstra, L., Wagner, D.R., Staessen, J.A., Heymans, S., Schroen, B., Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circ. Cardiovasc. Genet. 3 (2010), 499–506.
175. [175] Ji, X., Takahashi, R., Hiura, Y., Hirokawa, G., Fukushima, Y., Iwai, N., Plasma miR-208 as a biomarker of myocardial injury. Clin. Chem. 55 (2009), 1944–1949.
176. [176] Adachi, T., Nakanishi, M., Otsuka, Y., Nishimura, K., Hirokawa, G., Goto, Y., Nonogi, H., Iwai, N., Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin. Chem. 56 (2010), 1183–1185.
177. [177] Nabiałek, E., Wańha, W., Kula, D., Jadczyk, T., Krajewska, M., Kowalówka, A., Dworowy, S., Hrycek, E., Włudarczyk, W., Parma, Z., Michalewska-Włudarczyk, A., Pawłowski, T., Ochała, B., Jarząb, B., Tendera, M., Wojakowski, W., Circulating microRNAs (miR-423-5p, miR-208a and miR-1) in acute myocardial infarction and stable coronary heart disease. Minerva Cardioangiol. 61 (2013), 627–637.
178. [178] De Rosa, S., Fichtlscherer, S., Lehmann, R., Assmus, B., Dimmeler, S., Zeiher, A.M., Transcoronary concentration gradients of circulating microRNAs. Circulation 124 (2011), 1936–1944.
179. [179] Liebetrau, C., Möllmann, H., Dörr, O., Szardien, S., Troidl, C., Willmer, M., Voss, S., Gaede, L., Rixe, J., Rolf, A., Hamm, C., Nef, H., Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy. J. Am. Coll. Cardiol. 62 (2013), 992–998.
180. [180] van Rooij, E., Marshall, W.S., Olson, E.N., Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circ. Res. 103 (2008), 919–928.
181. [181] Montgomery, R.L., Hullinger, T.G., Semus, H.M., Dickinson, B.A., Seto, A.G., Lynch, J.M., Stack, C., Latimer, P.A., Olson, E.N., van Rooij, E., Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 124 (2011), 1537–1547.
182. [182] Satoh, M., Minami, Y., Takahashi, Y., Tabuchi, T., Nakamura, M., Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy. J. Card. Fail. 16 (2010), 404–410.
183. [183] Wilson, K.D., Shen, P., Fung, E., Karakikes, I., Zhang, A., Rahatloo, K.I., Odegaard, J., Sallam, K., Dawis, R.W., Lui, G.K., Ashley, E.A., Scharfe, K., Wu, J.C., A rapid, high-quality, cost-effective, comprehensive, and explandable targeted next-generation sequencing assay for inherited heart diseases. Circ. Res. 117 (2015), 603–611.
184. [184] Kakimoto, Y., Kamiguchi, H., Ochiai, E., Satoh, F., Osawa, M., MicroRNA stability in postmortem FFPE tissues: quantitative analysis using autoptic samples from acute myocardial infarction patients. PLoS One, 10, 2015, e0129338.
185. [185] Miki, K., Endo, K., Takahashi, S., Funakoshi, S., Takei, I., Katayama, S., Toyoda, T., Kotaka, M., Takaki, T., Umeda, M., Okubo, C., Nishikawa, M., Oishi, A., Narita, M., Miyashita, I., Asano, K., Hayashi, K., Osafune, K., Yamanaka, S., Saito, H., Yoshida, Y., Efficient detection and purification of cell populations using synthetic microRNA switches. Cell Stem Cell 16 (2015), 699–711.
186. [186] Xu, Z., Han, Y., Liu, J., Jiang, F., Hu, H., Wang, Y., Liu, Q., Gong, Y., Li, X., MiR-135b-5p and MiR-499a-3p promote cell proliferation and migration in atherosclerosis by directly targeting MEF2C. Sci. Rep., 5, 2015, 12276.
187. [187] Pagiatakis, C., Gordon, J.W., Ehyai, S., McDermott, J.C., A novel RhoA/ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression. J. Biol. Chem. 287 (2012), 8361–8370.
188. [188] Sluijter, J.P., van Mil, A., van Vliet, P., Metz, C.H., Liu, J., Doevendans, P.A., Goumans, M.J., MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler. Thromb. Vasc. Biol. 30 (2010), 859–868.
189. [189] Yeung, F., Chung, E., Guess, M.G., Bell, M.L., Leinwand, L.A., Myh7b/miR-499 gene expression is transcriptionally regulated by MRFs and Eos. Nucleic Acids Res. 40 (2012), 7303–7318.
190. [190] Wang, X., Ono, Y., Tan, S.C., Chai, R.J., Parkin, C., Ingham, P.W., Prdm1a and miR-499 act sequentially to restrict Sox6 activity to the fast-twitch muscle lineage in the zebrafish embryo. Development 138 (2011), 4399–4404.
191. [191] Jackson, H.E., Ingham, P.W., Control of muscle fibre-type diversity during embryonic development: the zebrafish paradigm. Mech. Dev. 130 (2013), 447–457.
192. [192] Warkman, A.S., Whitman, S.A., Miller, M.K., Garriock, R.J., Schwach, C.M., Gregorio, C.C., Krieg, P.A., Developmental expression and cardiac transcriptional regulation of Myh7b, a third myosin heavy chain in the vertebrate heart. Cytoskeleton (Hoboken) 69 (2012), 324–335.
193. [193] Ai, J., Zhang, R., Li, Y., Pu, J., Lu, Y., Jiao, J., Li, K., Yu, B., Li, Z., Wang, R., Wang, L., Li, Q., Wang, N., Bell, M.L., Buvoli, M., Leinwand, L.A., Uncoupling of expression of an intronic microRNA and its myosin host gene by exon skipping. Mol. Cell. Biol. 30 (2010), 1937–1945.
194. [194] Bhuiyan, S.S., Kinoshita, S., Wongwarangkana, C., Asaduzzaman, M., Asakawa, S., Watabe, S., Evolution of the myosin heavy chain gene MYH14 and its intronic microRNA miR-499: muscle-specific miR-499 expression persists in the absence of the ancestral host gene. BMC Evol. Biol., 13, 2013, 142.
195. [195] Dorn, G.W. 2nd, Matkovich, S.J., Eschenbacher, W.H., Zhang, Y., A human 3′ miR-499 mutation alters cardiac mRNA targeting and function. Circ. Res. 110 (2012), 958–967.
196. [196] Shieh, J.T., Huang, Y., Gilmore, J., Srivastava, D., Elevated miR-499 levels blunt the cardiac stress response. PLoS One, 6, 2011, e19481.
197. [197] Matkovich, S.J., Hu, Y., Eschenbacher, W.H., Dorn, L.E., Dorn, G.W. 2nd., Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy. Circ. Res. 111 (2012), 521–531.
198. [198] Zhang, L., Chen, X., Su, T., Li, H., Huang, Q., Wu, D., Yang, C., Han, Z., Circulating miR-499 are novel and sensitive biomarker of acute myocardial infarction. J. Thorac Dis. 7 (2015), 303–308.
199. [199] Olivieri, F., Antonicelli, R., Lorenzi, M., D'Alessandra, Y., Lazzarini, R., Santini, G., Spazzafumo, L., Lisa, R., La Sala, L., Galeazzi, R., Recchioni, R., Testa, R., Pompilio, G., Capogrossi, M.C., Procopio, A.D., Diagnostic potential of circulating miR-499-5p in elderly patients with acutenon ST-elevation myocardial infarction. Int. J. Cardiol. 167 (2013), 531–536.
200. [200] Xiao, J., Shen, B., Li, J., Lv, D., Zhao, Y., Wang, F., Xu, J., Serum microRNA 499 and microRNA-208a as biomarkers of acute myocardial infarction. Int. J. Clin. Exp. Med. 7 (2014), 136–141.
201. [201] Devaux, Y., Vausort, M., Goretti, E., Nazarov, P.V., Azuaje, F., Gilson, G., Corsten, M.F., Schroen, B., Lair, M.L., Heymans, S., Wagner, D.R., Use of circulating microRNAs to diagnose acute myocardial infarction. Clin. Chem. 58 (2012), 559–567.
202. [202] Chen, X., Zhang, L., Su, T., Li, H., Huang, Q., Wu, D., Yang, C., Han, Z., Kinetics of plasma microRNA-499 expression in acute myocardial infarction. J. Thorac Dis. 7 (2015), 890–896.
203. [203] Wang, J., Jia, Z., Zhang, C., Sun, M., Wang, W., Chen, P., Ma, K., Zhang, Y., Li, X., Zhou, C., miR-499 protects cardiomyocytes from H2O2-induced apoptosis via its effects on Pdcd4 and Pacs2. RNA Biol. 11 (2014), 339–350.
204. [204] Taira, N., Nihira, K., Yamaguchi, T., Miki, Y., Yoshida, K., DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage. Mol. Cell 25 (2007), 725–738.
205. [205] Castrogiovanni, C., Vandaudenard, M., Waterschoot, B., De Backer, O., Dumont, P., Decrease of mitochondrial p53 during late apoptosis is linked to its dephosphorylation on serine 20. Cancer Biol. Ther. 16 (2015), 1296–1307.
206. [206] Wang, J.X., Jiao, J.Q., Li, Q., Long, B., Wang, K., Liu, J.P., Li, Y.R., Li, P.F., miR-499 regulates mitochondrial dynamics by targeting calcineurin anddynamin-related protein-1. Nat. Med. 17 (2011), 71–78.
207. [207] Estaquier, J., Arnoult, D., Inhibiting Drp1-mediated mitochondrial fission selectively prevents the release of cytochrome c during apoptosis. Cell Death Differ. 14 (2007), 1086–1094.
208. [208] Li, X., Wang, J., Jia, Z., Cui, Q., Zhang, C., Wang, W., Chen, P., Ma, K., Zhou, C., MiR-499 regulates cell proliferation and apoptosis during late-stage cardiac differentiation via Sox6 and cyclin D1. PLoS One, 8, 2013, e74504.
209. [209] Iguchi, H., Urashima, Y., Inagaki, Y., Ikeda, Y., Okamura, M., Tanaka, T., Uchida, A., Yamamoto, T.T., Kodama, T., Sakai, J., SOX6 suppresses cyclin D1 promoter activity by interacting with beta-catenin and histone deacetylase 1, and its down-regulation induces pancreatic beta-cell proliferation. J. Biol. Chem. 282 (2007), 19052–19061.
210. [210] Hosoda, T., Zheng, H., Cabral-da-Silva, M., Sanada, F., Ide-Iwata, N., Ogórek, B., Ferreira-Martins, J., Arranto, C., D'Amario, D., del Monte, F., Urbanek, K., D'Alessandro, D.A., Michler, R.E., Anversa, P., Rota, M., Kajstura, J., Leri, A., Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation 123 (2011), 1287–1296.